Arix Bioscience バランスシートの健全性
財務の健全性 基準チェック /66
Arix Bioscience has a total shareholder equity of £239.1M and total debt of £0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are £240.5M and £1.4M respectively. Arix Bioscience's EBIT is £8.2M making its interest coverage ratio -2.4. It has cash and short-term investments of £101.0M.
主要情報
0%
負債資本比率
UK£0
負債
| インタレスト・カバレッジ・レシオ | -2.4x |
| 現金 | UK£100.99m |
| エクイティ | UK£239.12m |
| 負債合計 | UK£1.41m |
| 総資産 | UK£240.53m |
財務の健全性に関する最新情報
更新なし
財務状況分析
短期負債: ARIX's short term assets (£103.4M) exceed its short term liabilities (£1.4M).
長期負債: ARIX has no long term liabilities.
デット・ツー・エクイティの歴史と分析
負債レベル: ARIX is debt free.
負債の削減: ARIX has not had any debt for past 5 years.
債務返済能力: ARIX has no debt, therefore it does not need to be covered by operating cash flow.
インタレストカバレッジ: ARIX has no debt, therefore coverage of interest payments is not a concern.